Clinical Trials
9 trialsNCT02201381 2022-07-18
METRICS
Health Clinics Limited
Phase 3 Withdrawn
NCT00509444 2017-04-20
CPTD
Johns Hopkins Bloomberg School of Public Health
Phase 3 Completed
NCT00003674 2016-07-13
Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00026117 2016-07-13
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00000611 2016-04-15
Women's Health Initiative (WHI)
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3 Completed
NCT00305643 2015-12-24
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00538850 2014-03-05
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Phase 3 Completed
NCT00002455 2013-08-07
Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00559858 2013-08-02
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown